PDIA5 and sarcoma: There were positive correlations between the expression level of PDIA5 and MMR genes in most cancers except DLBC, GBM, acute myeloid leukemia (LAML), mesothelioma (MESO), sarcoma (SARC), and uterine carcinosarcoma (UCS) (Figure 1E).